职业发展

Media Coverage

Revitalizing the Northeast: Lakeshore Biopharma Leads the Way | Lakeshore Biopharma Selected as an Outstanding Enterprise by Liaoning’s Provincial Government and Featured in a Showcase Media Event

2024-06-20

1718700327824.jpg



In May 2024, Fan Jiying, Secretary of the Party Leadership Group of the Standing Committee of the Shenyang Municipal People's Congress, led a delegation to conduct an on-site assessment of Lakeshore Biopharma. Subsequently, the Liaoning Provincial Party Committee and Provincial Government selected Lakeshore Biopharma to participate in the "Liaoning Province Outstanding Enterprises and Institutions Interview and Showcase Event."


Prior to the event, the "Outstanding Enterprise Showcase" program team from Liaoning Radio and Television Station visited Lakeshore Biopharma, filming the company’s production facilities and office space. The program team delved into how Lakeshore Biopharma has transformed its R&D, production, and operations. The showcase was broadcast simultaneously on Liaoning Television Station’s Film and Television Channels on May 26, 2024.


For many years, Lakeshore Biopharma has been dedicated to the research and development of innovative vaccines, conducting numerous clinical studies both domestically and internationally. The company’s efforts have earned it prestigious accolades such as being recognized as a National High-Tech Enterprise and a Provincial Green Factory. The showcase has served as a platform for a wider audience to gain insights into Lakeshore Biopharma’s remarkable accomplishments in technological innovation, talent cultivation, and the biopharmaceutical industry, further enhancing the company's brand image As Lakeshore Biopharma looks to the future, it remains steadfast in its mission of “quality first, service foremost.” The company is committed to continuous innovation and aims to make significant contributions to the growth of China’s biopharmaceutical industry and the comprehensive revitalization of Northeast China’s industrial base.